Investing in Personalized Surgery
Insight Surgery is backed by investors who share our aim: to make patient-specific surgical planning and devices available to every surgeon who needs them, in the US and the UK.
Backed by Specialist Investors
Nodenza Venture Partners
A venture fund investing in innovative MedTech and life science companies. Nodenza’s Managing Partner, Ross Morton, sits on the Insight Surgery board.
Read the announcementFenwall Investments
An existing investor in the company when it traded as 3D LifePrints, Fenwall re-invested to lead the £1.2m round in 2020.
Read the announcementNodenza Venture Partners
In 2025 Nodenza Venture Partners led Insight Surgery’s $2.5m Series A. The investment followed FDA 510(k) clearance for our orthopedic and orthopedic-oncology surgical guides, and is funding our growth in the US: manufacturing at the Texas Medical Center in Houston, and a hub inside Children’s Nebraska in Omaha.
Nodenza’s Managing Partner, Ross Morton, joined the Insight Surgery board as a Non-Executive Director.
“Insight Surgery are the archetype of innovative MedTech businesses that Nodenza has invested in. They are delivering value to patients and surgeons today, not tomorrow. With the benefit of our support the team is poised to become a global market leader including US personalized surgery market.”
Invest in Insight Surgery
We are always glad to talk to investors who share our view of personalized surgery: specialist funds, strategic partners and individuals with experience in medical technology.
If you would like to learn more about the company and its plans, please get in touch.